The Genetic Causes of Male Infertility in Iranian Population; A systematic Review by Azizi, Faezeh et al.
 
This open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 Li-
cense (CC BY-NC 3.0). Downloaded from: www.jmp.iums.ac.ir 
1 Men’s Health Journal. 2018; 2 (1); e1 
Systematic Review 
The Genetic Causes of Male Infertility in Iranian Population; A 
systematic Review 
Faezeh Azizi1, Mir Davood Omrani2, Mohammad Ali Sadighi Gilani3, Jalil Hosseini*4 
1. Infertility and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 
2. Department of Medical Genetics, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, 
Iran. 
3. Department of Urology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. 
4. Infertility and Reproductive Health Research Center, Shahid Beheshti Medical University, Tehran, Iran. 
 
Received: March 2018; Accepted: May 2018; Published online: 20 June 2018  
Abstract: Introduction: Infertility affects an estimated 15% of couples globally and in Iran, a quarter of cou-
ples experiences primary infertility. Males are found to be individually responsible for 20-30% of 
infertility cases and contribute to 50% of cases totally. When assisted reproductive technologies 
(ARTs) are used to acquire pregnancy, a sufficient (epi) genetic diagnosis of male infertility (MI) is 
of main matter to consider if a genetic abnormality will be transmit-ted to offspring. Infertility cen-
ters together with Infertility research centers had been founded since 1994 in Iran and many arti-
cles from research projects have been published.  
Materials and Methods: This literature investigated the possible genetic causes mechanisms un-
derlying Iranian male infertility by extensive article searches.  First, we reviewed available data 
from the Google Scholar, PubMed, Scopus, Web of Science, IranMedex, MEDLIB, IranDoc and Scien-
tific Information Database were searched for articles published until 2018, using the MeSH terms 
for a variety of chromosome abnormalities, Y-chromosome microdeletions, gene mutations, expres-
sion and polymorphisms, Male infertility and/or Iranian, regional and international population, to 
provides the evidence- based and a comprehensive, up-to- date evaluation of the multifactorial fac-
tors involved in Iranian infertile men.    
Results: According to the strategy adopted initially, 274 manuscripts were found. After reviewing 
the titles, abstracts and manuscripts entirely cited, the total of 139 articles were obtained and se-
lected according to the eligibility criteria. The 139 studies were divided into four predetermined 
categories that mentioned above.  Studies have good methodological validity. The sample is quite 
heterogeneous, given the very different design of the studies.  
Conclusion: MI is a complex, multi-factorial disease and the underlying reasons frequently remain 
unknown. It seems that the first line of genetic diagnosis in Iranian male infertility is similar to 
Global One. In all investigations conducted in Iran, there are vacancies in studies such as epigenetic 
modification studies, RNA (lncRNA, miRNA and piRNA) abnormalities, mutation detection and pol-
ymorphism studies in other genes involved in the spermatogenesis process. At present, we have a 
little information for some polymorphisms (MTHFR, GST, ER, and DAZL) and mutations (mtDNA, 
CATSPER) which require more extensive studies. Such articles help to find a better insight into the 
causes of infertility in the Iranian men's community and will provide valuable visions into the de-
velopment of targeted personalized treatments for patients and the ascertainment of the reasons of 
idiopathic infertility. 
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1. Introduction 
nfertility is a usual obstacle affecting approximately 
15% of a couple in the world (1) but in Iran,   a quar-
ter   of   couple experience  primary I 
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infertility, which is above the global average (2). Male 
infertility is a complex disorder that in more than half of 
infertile men, the cause of their infertility is idiopathic 
and could be acquired or congenital.  In approximately 
15% of men, there are genetic abnormalities that in-
clude chromosomal abnormalities and single-gene mu-
tations. However, patients with some genetic abnormal-
ities (such as chromosomal changes and chromosome Y 
deletions) produce more aneuploid sperms (1). Albeit 
the majority of the genetic causes of male infertility are 
still unclear. The cause of aneuploid sperm is a misdiag-
nosis of meiosis due to the modified testicular environ-
ment (3). There is a risk of genetic abnormalities trans-
mitted through ICSI, which is even likely to occur in peo-
ple with normal sperm, as they can also have genetic de-
fects (e.g. 47, XYY men). Natural selection prevents the 
transmission of infertility mutations; however, fertility 
methods perhaps overcome this protective mechanism. 
The result is an increase in the genetic causes of infertil-
ity in the future and hence identification of genetic fac-
tors in the better management of infertile couples can 
be useful (4). This review discusses the genetic causes 
of Iranian male infertility known to date, and ultimately 
examines the polymorphism that may be associated 
with male infertility. 
 
2. Method 
2.1. Search strategy and databases 
A complete literature review was performed to retrieve 
the original Farsi and English language papers about 
“The genetic causes of male infertility among Iranian 
men population”, a systematic search was performed on 
international and Iranian databases including Web of 
Science, Google Scholar, PubMed, Scopus, IranMedex, 
MED-LIB, IranDoc and Scientific Information Database 
(SID). All relevant papers which contained the selected 
key terms (chromosome abnormalities, Y- chromosome 
Microdeletions, gene mutations, gene expression, poly-
morphism, Male infertility and/or Iranian, regional and 
international population) and published until May 
2018, were included. Moreover, the reference lists of the 
extracted articles were checked to find other helpful 
sources. 
2.2. Selection criteria 
The selection of papers occurred firstly through the 
analysis of titles and abstracts/summaries. The analysis 
of the manuscripts followed the predetermined eligibil-
ity criteria for the inclusion criteria: (a) papers that had 
in the title at least a mixture of the terms outlined in the 
search strategy; (b) articles written in English or Farsi; 
(c) papers had been published and indexed in one of the 
above-mentioned databases. The excluded elements en-
compassed: (1) non-original studies such as Letters to 
the Editor, Prefaces, brief communication, Correc-
tions/Editorials, and Monographs. (2) Papers repeated 
in more than one database were counted just once. 
2.2. Data extraction 
Each sample item was read in its entirety, and the infor-
mation was recorded into a spreadsheet that included 
authors, year of publication, sample statement of the 
study and major findings.  Some of the papers found fo-
cused on the theme of male infertility correlated to 
other causes that it is not the genetic factors. In fact, this 
re-view focused on male infertility as resulting from ge-
netic causes of male infertility in Iranian population, 
correlated data to other elements were not analyzed. 
Due to het-erogeneity in the literature, a qualitative 
analysis was carried out. Reference lists of all included 
full-text manuscripts were screened for additional arti-
cles. Authors of papers were contacted to ask clarifica-
tion where inadequate information was provided.  Ac-
cording to the strategy adopted initially, 274 manu-
scripts were found. After reviewing the titles, abstracts 
and manuscripts entirely cited, the total of 139 articles 
were obtained and selected according to the eligibility 
criteria. The 139 studies were divided into four prede-
termined categories: "chromosomal abnormalities, Y-
chromosome microdeletions, gene mutations and gene 
polymorphisms of male infertility in Iran".  Studies have 
good methodological validity. The sample is quite heter-
ogeneous, given the very different design of the studies.  
 
3. Result 
3.1. Genetic causes of male infertility: 
Genetic anomalies have been recognized in men with ol-
igozoospermia and azoospermia, overlay in review arti-
cles genetic factors involved in male infertility pre-sent 
as chromosomal abnormalities, gene mutations and pol-
ymorphisms, mitochondrial DNA mutations, mono-
genic disorders, multifactorial disorders and endocrine 
disorders of genetic origin (1) (Fig.1) (Table1) (3,5-22). 
For each category, we explain focused finding of Iranian 
articles and compare with regional and international ar-
ticles. 
3.2. Chromosomal Abnormalities 
The prevalence of chromosomal abnormalities is higher 
in IM, and this has a negative relevance with sperm qual-
ity. The results of the investigations display that the 
prevalence of chromosomal anomalies in infertile men 
varies from 5 to 13%. This value is increased to 15% in 
men with azoospermia, most of which are related to 47, 
XXY patients. Anomalies in sexual chromosomes are 
higher than autosomal, but a broad range of structural 
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anomalies of autosomal is also found (23). In a study of 
433 infertile males, with 169 azoospermia and 264 oli-
gospermia, it was found that there were 17.3% chromo-
somal problems, in which 14.3% and 3% of all cases ex-
hibited numerical and structural abnormalities, respec-
tively (5). In a comprehensive study to evaluate 829 in-
fertile men, the incidence of chromosomal abnormali-
ties is estimated to be 32.81%, of which 23.52% is 47, 
XXY and was the most frequent aberration (6). In an-
other study, 1052 infertile men cases were analyzed 
that 15.30% had chromosomal abnormality and 22.98% 
of them showed structural abnormalities. 47, XXY found 
in 58.38% of patients and was the most frequent aber-
ration in this study (7). Furthermore, in 2007, research-
ers analyzed 874 infertile men that 15.5% of patients 
had chromosomal abnormality, from which 13.2% 
showed sex chromosome abnormalities and 2.3% auto-
somal chromo-some abnormalities, respectively (8). 
When new methods such as ICSI were used, the preva-
lence of chromosomal abnormalities were increased. 
Therefore, the karyotype of blood cells is strongly rec-
ommended for men with severe oligspermia and azoo-
spermia. Even in cas-es where spermatic parameters 
are within the natural range or have slight changes, cy-
togenetic testing is recommended because some karyo-
type abnormalities such as 47, XYY or some chromoso-
mal translocations can cause infertility, while the indi-
vidual is normal for se-men analysis (9). The percentage 
of chromosomal ab-normalities among infertile men dif-
fers in various studies. For instance, in a cytogenetic sur-
vey in a 1792 Dutch infertile men, as low as 72 cases 
(4%) with chromosomal abnormalities were described 
and 47, XXY was found in merely 12 patients (0.6%). 
Also, in Germany, the results of a large study on 781 in-
fertile couples showed that, the rate of chromosomal ab-
errations was just 1.9% for the male subjects including 
sex chromosome abnormalities (0.6%). Due to the fair 
control and easy accessibility of cases to clinical genet-
ics laboratories, the rates of chromosomal abnormality 
among European countries could be low. The results of 
the study on 489 azoospermia Chinese men reported 
that 102 (20.86%) cases had chromosomal abnormali-
ties, among them, 86 (84.31%) cases had a sex chromo-
some abnormalities and 73 (14.9%) 47, XXY karyotype. 
In non-European countries, fewer published papers are 
available on cytogenetic studies of infertile men, but all 
representation rather high rates of chromosomal abnor-
malities among infertile populations. For example, 
among 1000 infertile men in India, about 14% had a 
chromosomal abnormality and in a study on 179 men 
with infertility in Turkey, 21 (11.49%) cases had chro-
mosomal abnormalities, including 13 (7.2%) cases with 
47, XXY syndrome (1, 7). The results of a large study on 
1,052 Iranian infertile men show an increase in chromo-
somal aberration. Total chromosome anomalies were 
revealed in 161 (15.30%) infertile men. The most fre-
quent chromosomal alteration was 47, XXY, which was 
seen in 94 (58.38%) men while one of them had a mo-
saic karyotype: mos 47, XX [54]/47, XXY [18]/46, XY [9]. 
In 37 (22.98%) cases, structural alterations were 
founded. The cases of sex reversal were 30 (18.63%) 
(6). In a study conducted by Monabati et al. on 433 in-
fertile men in Iran, it was showed that there is a corre-
lation between infertility and autosomal translocation 
Table 1: The average of frequency of the most common genetic causes in infertile men population. 
Name of Article % Chromosomal ab-
normality 
% Y chromosome mi-
crodeletion 
% Congenital bilateral ab-
sence of vaso deferan 
Azimi C.2012. 32.81%   
Akbari MT. 2012. 13.96% 
Monabati A. 2016. 17.3% 
Mahjoubi F. 2010. 15.30% 
Salahshourifar I. 2007. 15.5% 
Mozdarani H. 2008. 5.8% 
Shaveisi-Zadeh F. 2017. 6.5% 
Totonchi M.2012.  5.06 % 
Pouriamanesh S. 2016. 10.66% 
Masoudi R. 2016. 7.4% 
Saliminejad K. 2012. 2.13% 
Asadi F. 2017. 5.2% 
Zaimy MA. 2013. 8% 
Malekasgar AM.2008. 52% 
Omrani MD.2006. 24.2% 
Mirfakhraie R.2010. 12% 
Heidari S.2017.  1 % 
Safinejad K. 2011. 9.43% 
Radpour R.2008. 4% 
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among severe-oligo / azoospermic patients. In this re-
search, reciprocal translocation t (16; 20) (0.2%), rob 
(2; 21) (0.2%), rob (13;15) (0.2%) and rob (13;21) 
(0.2%) were identified in oligospermic males, while t 
(Y;19) did in one azoospermic case. The accurate mech-
anism by which chromosomal anomalies induces infer-
tility is not fully realized. While reciprocal translocation 
covering Y and an autosomal chromosome is ordinarily 
associated with azoospermia, balanced reciprocal trans-
location covering two autosomal chromosomes is per-
haps associated with decreased sperm count and maybe 
recurrent abortion (5). 
3.3. Sex chromosomal abnormalities Klinefelter 
syndrome (KS) and mosaics [46, XY / 47, XXY; 47, 
XXY] 
This syndrome is the most common aneuploidy of sex 
chromosomes in humans, the incidence of KS is found 
about was 9.45% in Iran (23). About 4.5% of oligosper-
mic men and 9% of azoospermic men have this syn-
drome. More than 90% of 47, XXY men are non-mosai-
cazoospermic. Of course, it is possible that in some of 
these individuals, spermatogenesis will occur. It has 
been considered that more than 90% of non-mosaic 47, 
XXY males are azoospermic (24, 25). Combination stud-
ies of ICSI and PGD on embryos in patients with Kline-
felter syndrome show that the rate of formation of ab-
normal embryos is higher than that of healthy people, 
therefore, PGD or PND is strongly recommended for 
them (26,27). 
3.4. Other sex chromosomal abnormalities 
The 47, XYY karyotype is the second most common an-
euploidy of the sex chromosomes. Most of the FISH-
based studies on XYY male sperm indicate an increased 
incidence of sexual chromosomal abnormalities. How-
ever, no evidence of increased aneuploidy risk has been 
found in the children of these men (28). Karyotype 46, 
XX is commonly seen in 0.8% azoospermic men. The 
phenotype is similar to Klinefelter syndrome, but with 
natural height and intelligence. SRY gene is present in 
most cases (SRY + XX), but these infertile men are azoo-
spermic be-cause of testicular atrophy (29). The next 
group of men is SRY-XX which has a mutation in an au-
tosomal gene or a continuous X gene that should be the 
successor to SRY in the sex determination process and 
allow the development of the testes in the absence of 
SRY (1, 29). Y chromosome rearrangement in male in-
fertile men, especially in azoospermic men, increases. 
The association of phenotype of infertility with AZF 
(Yq11.23) region rear rangements (Yq reversals and de-
letions) has been widely studied. The loss of Yq is not 
detectable by karyotype (10, 30). On the other hand, 45, 
X/46, XY mosaicism is an infrequent karyotype, and its 
outbreak is about 1.5 in 10,000 newborns. It has an ef-
fect on the hormonal bal-ance, growth, gonad develop-
ment and histology. In 45, X/46, XY cases, both 45, X and 
46, XY cell lines are detect-ed. Diverse distributions of 
both cell lines can reflect a large range of phenotypes, 
hence, it seems that karyotyping as a major diagnostic 
test can enable specialists to detect these rare cases 
(31). 
3.5. Sex chromosomal translocations 
The phenotypic or reproductive effects of X-Autosomal 
translocations are different based on the sex-chromo-
some carrier (male or female), the fracture points, and 
Table 2: The prevalence of genetic abnormalities and related phenotypes associated with Iranian infertile men. 
Genetic disorder Phenotype Prevalence 
Chromosomal anomalies: 
Klinefelter syndrome 








   10-15 % 
   9 % 
   0.2 % 
   1 % 
   1 % 
Y-chromosome microdeletion (YCM) (1)1    12 % 
Gene mutations: 
CFTR gene (CBAVD) 
Other mutations: 








   2-5 % 




CAG repeats in exon 1 gene of AR 
Haplotypes of Y chromosome 
MTHFR gene 

















1 Azo-severe oligospermia 
2 Azoospermia 
3 Cryptorchidism 
4 Azoospermia to normal 
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the inactivation pattern of the chromosome. Particu-
larly in men, can cause azoospermia although a few 
cases have been published with oligozoospermia (5, 7, 
29).  
3.6. Autosomal abnormalities 
The most common autosomal abnormalities are Robert-
sonian translocations, Reciprocal translocations, Para-
centric inversions and marker chromosomes. Similar to 
Klinefelter syndrome, the FISH method is very effective 
in identifying a disorder. Performing PGD or amniocen-
tesis seems essential (1). 
3.7. Robertsonian and Reciprocal translocations 
Robertsonian occurs when two acrocentric chromo-
somes are connected to each other. The prevalence rate 
of Robertsonian translocation is 0.9% in infertile males, 
this rate is more than general population. Fertility prob-
lems in men with Robertsonian translocation are due to 
disturbances in the distribution of meiosis and, as a re-
sult, damage to spermatogenesis (1). Reciprocal trans-
location is detected in 0.9 of 1000 newborns and involve 
the exchange of chromosome parts between the two 
urelated chromosome segments. There is no phenotypic 
change in carriers. The magnitude of this disorder is 
higher in oligo/azoospermic patients than normal indi-
viduals. Carriers produce more unbalanced sperm that 
is due to disturbances in meiosis divisions (7, 32). Both 
of them are the most commonly observed structural 
chromosomal anomalies in humans. They have been 
found in approximately 1 % of infertile men and com-
monly occur in azoospermia compared to oligozoo-
spermia (1).  
3.8. Y chromosome microdeletions (YCMs) 
The role of YCMs, as the second most important genetic 
cause of male infertility, should not be neglected. The 
YCMs have been examined in many countries and so far, 
the incidence of microdeletions in AZF locus in infertile 
men has not been clarified, but according to different ar-
ticles, the world frequency of these microdeletions in in-
fertile males is about 1-55% (33). In the long arm of the 
Y chromosome, the proximal to the distal section is 
AZFa, b, and c, respectively. There are at least 14 gene 
coding proteins in the AZF locus. Deletion of these genes 
happens in six classic classes, containing AZFabc, AZFbc, 
AZFc, AZFb, AZFa, and partial elimination of AZFc. Most 
of these deletions are stated in areas b and c. In 57% of 
YCM cases, the partial and complete removal of AZFc has 
been observed. A total of 25-30% of the deletions are 
AZFb or AZFab and 65-70% of the observed deletions 
are related to AZFc. These high frequency of deletions 
should be confirmed through more precise studies (11). 
Also, Krausz (2013) has been shown that a significant 
proportion of sperm in men with YCM are nullisomic for 
sex chromosomes and can be a potential risk for new-
borns to develop Turner syndrome (45, XO) or other 
malformations and in mosaic patients 45, XO / 46, XY, 
which have a hermaphroditic sign, a high prevalence of 
AZFc have been observed (33). The fourth part of the 
AZF re-gion reported between AZFb and c, called AZFd, 
and associated with mild oligospermia. A group of re-
searchers believe that elimination of this locus can be a 
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polymorphism. The STS markers of the AZFd region are 
in fact located within the AZFc region and are eliminated 
in some types of AZFc partial deletions. There is now a 
general belief that AZFd is not present and the initial re-
port in this area is probably a technical error, therefore 
AZFd is not considered in a clinical setting (12). Based 
on comparison investigations done among infertile 
male’s population in Italy, France and Denmark, it has 
been assumed that under study populations and the ge-
ographical location are two impressive factors in the 
frequency of microdeletions. These factors can alter the 
frequency, more or less of worldwide statistical stand-
ards (33). Limited studies have been conducted in the 
Middle East, and the frequency of YCMs in Saudi Arabia, 
Turkey, and Kuwait has been reported to be 3.2; .3.3 and 
2.6, respectively. Previous studies carried out in Iran, 
the Y micro-deletion frequency has shown variable 
ranges from 5 to 52% which is within the range that has 
been reported worldwide. There are wide variations in 
the reported frequency of microdeletions in Iranian 
populations and this discrepancy maybe rooted in the 
patient’s selection criteria, genetic background and eth-
nicity. Furthermore, lack of consistency in protocols ap-
plied to detect micro-deletions and methodological er-
rors may lead to variation in the results in some of the 
studies done in Iran as mentioned by Masoudi et al (13). 
The meta-analysis study of, Omrani et al. in 2016 
showed that the frequency of such microdeletions was 
12.1% (95% CI, 6.5-22.6). Also, they mentioned, the fre-
quency of Y-chromosome microdeletions was higher in 
Gilan and Azerbaijan provinces. The higher incidence of 
microdeletions among these two ethnic groups might 
have been simply caused by the greater number of stud-
ies performed and the more information collected from 
these ethnicities (34). Masoudi et al. in 2016 demon-
strated that their data were consistent with the report 
by Saliminejad et al. in 2012, which showed a frequency 
of 2.13% of complete micro-deletions in the Y chromo-
some (13, 14). In a large study, by Asadi et al. 1885 in-
fertile men with azoospermia/severe oligospermia 
were examined for YCMs (27). Their results were in 
agreement with similar studies as Totonchi et al. and 
Zaimy et al. similar to the world researchers which have 
mostly reported a frequency of less than 10% (~5.4%) 
for YCMs (11, 16). Some of the Iranian investigations 
had methodological errors and some applied many STS 
markers while there are stand-ardized STS markers en-
dorsed by the EAA and EMQN which can find 95% of all 
reported AZF microdeletions (33). Although, despite the 
EAA and EMQN recommendation, the result of Now-
roozi et al., study, that comprised of fathers who had at 
least a son with ICSI due to severe oligospermia or azo-
ospermia (60 fathers was evaluated along with their 70 
sons) have been shown that YCMS is not prevalent in fa-
thers with successful ICSI and it is not urgent to be ana-
lyzed before ICSI (35,36). 
3.9. Gene Mutations 
Many autosomal, X-linked and mitochondrial genes are 
also being investigated for possible roles in Iranian male 
infertility. Many genes are required for sexual, testicular 
evolution and normal spermatogenesis, although only a 
small number of them are clinically important (4). These 
genes are the CFTR gene where the mutation is associ-
ated with CF and CBAVD, the androgen receptor gene, 
where the mutation is associated with androgen-sus-
ceptibility syndrome and spermatogenic disorder, the 
INSL3-LGR8 gene that mutations cause abnormalities 
and an impairment of testicular dysfunction and muta-
tions in the KALIG-1 gene that cause Kallmann syn-
drome (1). 
3.10. CFTR gene mutation 
Cystic fibrosis (CF) is the most common inherited disor-
der in Caucasian populations and a large part of adult 
males with CF (99%) has CBAVD. CBAVD is also encoun-
tered in 1- 2% of infertile males without CF (20). Nearly 
70% of men with CBAVD and no clinical evidence of CF 
have a known defect of CFTR gene. Nearly 10% of infer-
tile men with OA are congenital and caused by CF gene 
mutations. There are just a few publications that de-
scribe the distribution and frequency of CFTR gene mu-
tations in Iran (37, 38). In the 53 Iranian infertile men 
with CBAVD obstructive azoospermia, Safinejad et al. 
evaluated five common CFTR mutations (ΔF508, G542X, 
R117H, W1282X, and N1303K). The common CFTR mu-
tations were detected in 9/53(17%) cases (21). In an ex-
tensive research of CBAVD in Iran, among 120 cases of 
men with CBAVD, Radpour et al. identified 19 different 
mutations in Iranian CBAVD patients especially two mu-
tations, IVS8-5T and F508del, were recognized to be 
more com-mon in Iranian CBAVD patients. Also, they 
recommended, screening for the IVS8-5T and F508del 
together led to the identification more than one-third of 
alleles (22). Totally, distribution of CFTR mutations in 
the Iranian population appreciably varies from those 
published in the neighbouring countries like Turkey, Pa-
kistan, and Arabian countries. The Iranian patients were 
from 44 cities located in different geographic areas, the 
distribution and frequency of the most common CFTR 
mutations differ among these ethnic groups and geo-
graphic areas (38). Another study in infertile Indian 
males with non-obstructive azoospermia and spermato-
genic failure showed that ΔF508 mutation was pre-
sented in 3.6% of patients with non-obstructive azoo-
spermia (39). Because over 1,300 different mutations 
have been recognized in this gene, this type of limited 
analysis is only informative if a mutation is discovered. 
A negative test result just indicates that the CBAVD pa-
tient does not have the most common mutations causing 
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CF. Direct sequence analysis of the entire gene is 
commercially available but very ex-pensive. Since infer-
tility in many patients can be treated nowadays by ART, 
if couple are carrier of CFTR mutations, the risk of hav-
ing children with CF will be in-creased (4).  
3.11. INSL3-LGR8 gene mutations 
The pseudo insulin agent (INSL3), also recognized as the 
quasi-relaxin factor (RLF), is a member of the pseudo-
relaxin hormone family produced by Leydig cells. The 
prevalence of these mutations is reported to be 4-5% in 
men with cryptorchidism and ex-cryptorchidism. Data 
have stated that mutations in LGR8/GREAT or INSL3 
gene occur in nearly 5 % of men with cryptorchidism. 
Although, there is disagreement proof to trust that these 
pathologies could possibly be caused by mutations in 
other genes too.  It seems that this hormone has endo-
crine and paracrine functions in the adult population 
and its deficiency can be considered as an important 
sign for hypogonadism (1). 
3.12. Gene mutation of the Androgen Receptor 
Androgens and their active receptor (AR) are necessary 
for the development and preservation of male pheno-
types and spermatogenesis. AR is coded by a gene that 
is located on X chromosome and has 8 exons. Mutations 
in this gene cause a variety of disorders commonly re-
ferred to as androgenic insensitivity syndrome (AIS). 
Patients with a mild mood syndrome (MAIS) show in-
fertility alone or with other symptoms.  Although more 
than 700 mutations and polymorphisms have been re-
ported in the AR gene, only 5% of these mutations lead 
to the MAIS phenotype in which infertility may be the 
only symptom (40). In 2011 Mirfakhraei and et al. for 
the first time, presented p. Pro504Thr substitution, ac-
cording to previous reports on AR gene alterations, 8 
mutations have been determined in patients with azoo-
spermia and 4 of these mutations are located in exon 1, 
until then (41).  
3.13. The Kallmann (KAL-1) gene mutations 
The most commonly reported X-linked infertility is the 
Kallmann syndrome. This syndrome is due to the muta-
tion in the KAL-1 gene (Xp22.3). Of course, today, many 
other genes have been identified on other autosomal 
chromosomes. In 2015, Ahmadzadeh et al. studied on 8 
males and detected 5 male patients with hemizygous 
mutation (42). The main symptoms of a hypogonado-
tropic disease are hypogonadism and anosmia. Treat-
ment with gonadotropins can lead to normal pregnan-
cies, even in cases of low sperm concentration or Azoo-
spermia. Therefore, it is advisable to carry out a precise 
genetic consultation before engaging in ARTs and to es-
timate the risk of transmission by identifying the gene 
(1). 
3.14. The mitochondrial DNA (mtDNA)  
Recent information has represented that mtDNA multi-
ple deletions or point mutations, mtDNA single nucleo-
tide polymorphisms (SNPs) and mtDNA haplogroups 
can considerably impression sperm quality and are as-
sociated with asthenozoospermia or oligoasthenozoo-
spermia (43,44). Among the mitochondrial deletions 
detected, the deletion of 4977 bp was the most common 
Table 3: List of the gene mutations in Iranian infertile men. 
Gene Name Number of pa-
tients 
Mutation and deletion Reference 
DNAH1 10 c.8626-1G > A Amiri-Yekta A., 2016. 
DAZ  154 gr/gr deletions and b2/b3 were 
not significantly different. 
Alimardanian L., 2016. 
SEPT12 100 No mutation Hosseinifar H, 2014. 
NR5A1 90 missense mutations (p.P97T) Zare-Abdollahi D., 2015. 
FABP9 100 No mutation Jamshidi J., 2014. 
AR - 1510C→A trans version in exon 1 Mirfakhraie R., 2011. 
mtDNA 60 4977 and 7599 bp deletions Talebi E., 2017. 
mtDNA 256 4,977-bp deletion Bahrehmand Namaghi I., 
2017 
mtDNA 60 4977-bp deletion Gashti NG., 2014 
CATSPER1/2  c.539-540insT and c.948-949in-
sATGGC 
Kahrizi k., 2010. 
Kahrizi k., 2009. 
ESR β 96 (IVS 8–4G>A) near the 5’ splicing 
region of intron 8 
Omrani MD., 2005. 
MTHFR promoter hyper 
methylation 
55 No differences Khazamipour N., 2009. 
STRC and CATSPER2  contiguous gene deletions 
(15q15.3) 
Kahrizi k., 2007. 
USP26 166 370-371insACA, 1423C > T and 
494 T > C 
Asadpor U., 2013. 
sperm DNA damage with 
protamine deficiency 
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and numerous one (45). 
3.15. Other Mutations 
An unexpectedly high number of genes with a testis-
specific or enriched expression pattern have been rec-
ognized. Nonetheless, to date merely a few genes have 
been screened in Iranian population and none of them 
become manifest related to male infertility. In table 3, 
15 published articles in Iran have been summarized to 
show their finding in studied mutations on male fertility 
(46-57).  
3.16. Gene Polymorphisms 
In the last decade, a great number of researches focused 
on the recognition of gene variants affecting spermato-
genesis in human. Several studies have been carried out 
in this regard, which has not necessarily been accompa-
nied by similar outcomes, often due to the following fac-
tors: types of polymorphism and methods, the size and 
composition of the population studied, ethnic and geo-
graphic differences, multi-functional and heterogene-
ous phenotypes of male infertility. Various polymor-
phisms have been surveyed in several genes to specify 
their association with infertility in men, but many of 
them have not been repeatable, and hence no accurate 
results are available, except for some of these polymor-
phisms (1, 58). 
3.17. Haplotypes of Y chromosome 
In Masoudi et al. study, b2/b3 frequency equated to 
1.25% and gr/gr 5% in a case group and a control group 
of fertile males, 4% gr/gr microdeletions was detected 
while there were no b2/b3 microdeletions (13). In an-
other study, thirty oligozoospermia were examined for 
AZFc deletions. Six fertile men had partial deletions (five 
gr/gr and one b2/b3) with a higher level of FSH, LH in 
their group (p < 0.05) and in five patient’s partial dele-
tions in AZFc region (four had gr/gr and one had b2/b3 
deletions) had been identified. The role of b2/b3 dele-
tions in male sterility is still unclear because of its low 
frequency. It appears that the role of DAZ3/4 deletion in 
male sterility is limited to the b2/b3 sub deletion. 
Hence; more researches should be done for discovered 
the role of gr/gr deletion and b2/b3 sub deletion in the 
context of Y haplogroups (59). Overall, no definitive 
conclusions have been reached on the role of haplog-
roups in male infertility or its deletions (60, 61). 
3.18. Polymorphism in the Methylenetetrahy-
dro-folate reductase (MTHFR) gene 
MTHFR functions as a significant regulatory enzyme in 
folate metabolism. Genetic association study defined a 
significant association of MTHFR-222Val/Val genotype 
with oligozoospermia and azoospermia. Meta-analysis 
for allelic, showed a significant association between the 
Ala222Val polymorphism and the risk of male infertility 
(P < 0.001). The investigations showed significant asso-
ciation of MTHFR-Ala222Val with a risk of male infertil-
ity, especially in Asian population (62). 
Some studies have shown that there is a relationship be-
tween the C677T polymorphism and infertility in men, 
but there is no definitive conclusion that this is due to 
the heterogeneity of the selective population and racial 
differences. In fact, studies in Germany, India, and the 
United Kingdom showed homozygote (TT), heterozy-
gous (CT), and azo-oligospermic studies, while studies 
in the Dutch population did not show such an associa-
tion and the results of studies in Italy were also contra-
dictory (63-66). 
3.19. Polymorphism in the DAZL gene 
This gene is an autosomal homologous DAZ gene contin-
uous to Y, no mutations have been reported in this gene, 
except for two SNPs in exon 2 (A260G) and exon 3 
(A386G). There is no significant association between 
DAZL A386G and male infertility in Iranian population 
(67). However, in meta-analysis, within Asian popula-
tion, a significant association between DAZL A386G and 
male infertility has been found (68). 
3.20. The polymorphisms of the exon 1 of the an-
drogen receptor gene 
The androgen receptor 2 has a polymorphic site in exon 
1, due to the difference in the number of repetitions of 
CAG and GGC that produces polyglutamine and polygly-
cine strands of different lengths in the N region of the 
AR terminal protein terminal (69). A number of recent 
stud-ies have examined the association between CAG re-
peat length and infertility in men. The basis of these 
studies was that a loud repeat of CAG would reduce the 
AR transcription activity (70, 71). In a study of 307 Ira-
nian men, 104 infertile men with NOA and 203 fertile 
controls, a significant correlation between CAG repeat 
length and risk of non-obstructive was showed (72). In 
studies on patients in Singapore, Australia, North Amer-
ica, and Japan, there was a correlation between the 
length of repeated CAG and male infertility, while there 
was no such relationship in European populations. Re-
garding the distribution of GGC repeat lengths among 
infertile men, no difference was found in the natural 
population (73-75). An examination of these two repe-
titions simultaneously suggests that some haplotypes 
may affect AR activity and can predispose a person to 
infertility (69). 
3.21. Polymorphism in a polymerase gamma 
(POLG) gene 
Mutation in the POLG gene perhaps present a mutation 
in the mtDNA during replication, which finally could in-
fluence the motility of the spermatozoa. POLG gene in-
cluded a changeable number of CAG repeats, of which 10 
copies of CAG repeats were assumed as a common allele. 
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In a study, 40 Varicocele patients and 30 control had 
been analyzed for POLG polymorphism by Heidari et al. 
The results were negative for finding association (76) 
but contrary to this research, in different countries mul-
tiple studies have shown an association between several 
polymorphisms, mutations or deletions in the mito-
chondrial genome and sperm dysfunction (77,78). 
3.22. Polymorphism in Estrogen Receptor (ER) 
gene 
Polymorphisms of the ER genes have been signified in 
male infertility, however, comprehensive evidence are 
lacking. The most common polymorphisms are XbaI and 
PvuII of the ESR- α gene and, RsaI and Alul polymor-
phisms of the ESR- β gene (79). While the accurate role 
of estrogen receptors in male fertility situation is ac-
cepted, finding suggests that particular polymorphisms 
of the ER-α and ER-β genes which admit, a lower sex 
hormone binding globulin and therefore a stronger un-
bound estrogen effect, maybe unfavourably influence 
spermatogenesis (80,81). 
3.23. FSHR gene polymorphism 
Different Single Nucleotide Polymorphisms (SNPs) have 
been presented within FSH receptor (FSHR) gene that 
Table 4: List of the gene polymorphisms in Iranian infertile men. 
Gene name Cases/Controls Association Reference 
GST 166 / 166 Yes Safarinejad. R., 2010. 
TNFR1 36 108 / 119 Yes Ashrafzadeh HR., 2017. 
interleukin 1β 207 / 230 Yes Zamani-Badi T., 2017. 
FAS and FASL 102 / 110 Yes Asgari R1., 2017. 
AHR 135 / 130 No Aftabi Y., 2017. 
XRCC5, XRCC6 and XRCC7 178 / 214 Yes Jahantigh D., 2017. 
H2BFWT 109 / 123 Yes Rafatmanesh A, 2017. 
HIWI2 121 / 100 Yes Kamaliyan Z., 2017. 
INSR, SLC6A14, TAS2R38, and 
OR2W3 
96 / 100 Yes (for INSR  and 
SLC6A14) 
Siasi E, 2016. 
YBX2 180 / 96 Yes Najafipour R, 2016. 
FSHR 212 / 200 Yes Gharesi-Fard , 2015. 
SEPT12 67 / 100 Yes Shahhoseini M,2015. 
MTHFR 242 / 255 Yes Nikzad H, 2015. 
H2B.W 92 / 60 No Haji Ebrahim Zargar ,2015. 
PD-1 gene, G/A 61 / 84 Yes Zamani MR, 2015. 
USP26 72 / 60 Yes Asadpor U., 2013 
POLG CAG repeat 40 / 30 No Heidari MM, 2011. 
GST 95 / 26 No Lakpour N, 2013. 
PRM1, PRM2 and TNP2 96 / 100 No Siasi E, 2012. 
Tp53 110 / 180 Yes Mashayekhi F. 2012. 
GST and  CYP 150 / 200 Yes and No Salehi Z, 2012. 
ER-α and ER-β 164 / 164 Yes Safarinejad MR, 2010. 
protamine1 and protamine 2 273 / 35 No Salamian, 2008. 
ER-β 120 / 204 Yes Omrani MD, 2006. 
SPO11 100 / 100 No Karimian M., 2015. 
FSH-R 172 / 172 No Safarinejad M.,2010. 
SPATA16 130 / 110 No Roozbahani G.,j.mgene.2017. 
TAF7L gene 100 / 105 No Heidari , 2017. 
CPEB1 70 / 70 Yes Yadollahy,A., 2017. 
DAZ T > C 110 / 200 No Hadiyan S.P., 2015. 
Catalase 195 / 190 Yes Sabouhi S., 2014. 
MMP-2 200 / 200 Yes Mohagheghi A. 2015. 
KISS1R 50 / 50 Yes Poursharif A., 2017. 
HSPA1L 143 / 199 Yes Kohan L., 2016. 
GST 75 / 134 Yes Naghavi A., 2013. 
mir-34 b/c 244 / 105 Yes Majidi H., 2017. 
DAZL 100 / 100 Yes Nejati M., 2016. 
CHDH 50 / 50 Yes Ebrahimi M.,2014 
MOV10L1 30 / 70 Yes Sarkardeh H., 2014. 
RABL2B 60 / 30 Yes Hosseini SH., 2017. 
DEFB126 35 / 40 Yes Rostami Chayjan M, 2014. 
CGA 224 +196 Yes Jamalvandi M., 2018. 
DICER1 385 / 120 Yes Moghbelinejad, S., 2018. 
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may affect the receptor function. While some meta-anal-
yses have been reported that FSHR SNPs at positions 
A919G and A2039G did not play any roles in suscepti-
bility to spermatogenetic dysfunctions, sperm abnor-
malities, and azoospermia, in contrast to these studies, 
sever-al investigations presented a relationship be-
tween FSHR polymorphisms and azoospermia or infer-
tility (82). Gharesi-Fard et al. demonstrated that the 
presence of A allele at position 919 within FSHR gene 
might affect the receptor function and the FSH level. 
Both OA and NOA patients with the AA genotype at po-
sition 919 from FSHR had higher FSH plasma levels con-
trasted to those with AG or GG genotypes. In addition, 
the level of FSH was elevated in the OA patients with the 
AA genotype at FSHR A919G position (83). 
3.24. MicroRNA 
miRNAs are small, internal, single-stranded RNA mole-
cules that control gene expression and have been rolled 
in different disease. It has been evidenced that some 
miRNAs expression is tissue-specific and disease-spe-
cific, giving the potential for recognizing miRNAs as a di-
agnostic tool. About 60-75% of male infertility cases are 
idiopathic and their molecular mechanisms cause are 
unclear. Semen analysis and diagnostic tests are not 
precise in this cases (84, 85). Newly, it has been ex-
planted that microRNA like mir-100 and let-7b, mi-
croRNA-196, microRNA-99a were predicted to target 
ERα gene. The results of these investigations demon-
strate that miRNA can have a significant role in spermat-
ogenesis and per-haps have a diagnostic and prognostic 
value in men infertility (86, 87). On the other hand, pol-
ymorphisms in different noncoding genes such as HIWI 
genes contribute to spermatogenesis defects and can be 
assumed as risk factors for male infertility (88-90).  
3.25. Other polymorphisms 
Bearing in mind, the high predicted number of genes in-
volved in male gametogenesis, so mutations or poly-
morphisms in spermatogenesis genes can cause most 
idiopathic forms of spermatogenic disorders. Although, 
in spite of exhaustive survey of new genetic factors, no 
clinically related gene mutations or polymorphisms (ex-
cept those related to the Y-chromosome) have so far 
been known. In table 4, 44 published articles in Iran 
have been summarized to show their finding in studied 
polymorphisms and their genotypes on male fertility 
(56, 91-124). 
3.26. Gene Expression 
Disturbances in the expression of any effective gene in 
spermatogenic pathway is one of causes of male infer-
tili-ty (125). Recent investigations have revealed the 
pres-ence of about 3000 different kinds of mRNAs in 
ejaculat-ed spermatozoa. Albeit, the correlation of tran-
scriptome profile with male infertility remains ambigu-
ous (126). Table 5, published articles in Iran have been 
summarized to show their finding in studied gene mu-
tations on male fertility (127-131). As it is found, there 
is plenty of room for further studies. 
 
4. Discussion 
According to the above, it can be summarized as the 
main causes of infertility known in Iranian men are fre-
quently related to chromosome abnormalities. Kline-
felter syndrome and specific translocations are well-es-
tablished reasons of male infertility. Also two significant 
gene defect, definitively associated with spermatogenic 
failure, are the point mutations in the CFTR and AR 
genes. On the other hand, one of the most notable path-
ogenetic defects associated with Iranian male infertility 
is YCMD. De novo deletions of Yq are mostly happening 
chromosomal ab-normalities in infertile men and are 
believed to arise from recombination events between 
long stretches of highly repetitive DNA sequences dur-
ing meiosis or early pre-implantation development (10, 
38,132). To the best of our knowledge, this is the largest 
and most comprehensive literature review performed 
so far for the evaluation of the genetic causes of male in-
fertility in Iranian population. In 2017, a similar article 
was published by Mozdarani et al., which in detail refers 
to subjects such as protamine deficiency or sperm DNA 
damage. In general, the present paper considers a new 
perspective on the factors affecting male infertility in 
Iran (133). Despite the fact that a lot of genetic causes of 
Iranian male infertility are detected with chromosome 
typing, YCMD and CFTR mutation analysis, a large part 
remains unknown. Therefore, it seems that in such 
cases, the analysis of mutations and polymorphisms in 
the genes involved in the spermatogenesis process will 
be very important. In all investigations conducted in 
Iran, there are vacancies in studies such as epigenetic 
modification studies, RNA (lncRNA, miRNA and piRNA) 
abnormalities, mutation detection and polymorphism 
Table 4: List of gene expression in Iranian infertile men. 
Gene Name Cases Significant Reference 
TSGA10 84 Yes Aarabi M, 2006. 
Clusterin 42 Yes Mardi Mamaghani A., 2018. 
hTSH2B 15 Yes Faghihi Zohani, F., 2013. 
TGIFLX/Y 110 Yes Arabi M., 2008. 
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studies in other genes involved in the spermatogenesis 
process. At present, we have a little information for 
some polymorphisms (MTHFR, GST, ER, and DAZL) and 
mutations (mtDNA, CATSPER) which require more ex-
tensive studies. It was maybe an unavoidable conclusion 
that gaps in the literature would be identified. Although, 
what was surprising was the substantial nature of the 
gaps where efficiently little or sometimes no survey had 
been carried out. Although, vice versa, a number of sub-
jects were recognized with clear and significant oppor-
tunities for the way for-ward. Newly, further tests, such 
as chromatin fragmentation and ROS determination, 
have been suggested for research goals. In light of tran-
scriptome and proteome pro-filing analyses, investiga-
tors powerfully advocate for new markers of male fer-
tility or infertility that could include sperm and seminal 
plasma proteins or complex population of RNAs that are 
maintained in mature sperm (1,25,134). Due to the met-
acentric studies conducted by Iranian researchers from 
2005 to 2018 and considering the results of this review, 
it seems that the first line of genetic diagnosis in Iranian 
male infertility is similar to Global One. That means, Kar-
yotype and YCMD testing should be carried out on all 
males with severe oligozoo-spermia or non-obstructive 
azoospermia prior to any therapeutic procedure, and 
appropriate CFTR mutation analysis should be offered 
to all males with CBAVD or CF or his wife. Here are a few 
points to keep in mind, there are wide variations in the 
reported frequency of micro-deletions in Iranian popu-
lations and this discrepancy maybe rooted in the pa-
tient’s selection criteria, genetic background, ethnicity, 
lack of consistency in protocols applied to detect micro-
deletions and methodological errors, that all of them 
may lead to variation in the results in some of the stud-
ies done in Iran (4,6,33). For example, in a study have 
been reported a high frequency of AZFb microdeletion 
(66.67%) versus AZFc (41.67%) and researchers sug-
gested that AZFd could be negative for sY254 and sY255 
markers, while positive for either of sY145 or sY153 
STSs.  Their study along with several others also con-
flicts with this idea that the absence of sY254 and sY255 
indicates complete deletion of AZFc region. Also, it 
seems that at least sY153 is polymorphic and exists in 
multiple copies and should not be used in the study of Y 
chromosome microdeletions (20,135,136). On the other 
hand, the results of the research by Ghoraeian et al. 
highlighted an interesting point in the YCMD, based on 
their achievement; a presence of DAZ (Deleted in Azoo-
spermia) gene in somatic cells might not be suggestive 
of its presence in germ cell lineage. In addition, some se-
vere oligozoospermic men could be mosaic for the YCM 
in leukocytes but normal in the germ cell lineage. PCR 
based DAZ analysis does not display a status of DAZ 
gene in individual cells. There has been trying to display 
DAZ gene by the use of PRINS in lymphocytes either as 
interphase or metaphase cells or FISH on sperms or 
metaphase lymphocytes (137,138). It may be necessary 
to re-examine the YCM screening standards in accord-
ance with the needs of the Iranian infertile men's com-
munity and with the purpose of conducting ongoing 
studies, Iran-specific STR panel has been designed (47). 
On the other hand, so far, many different studies have 
been conducted in various ethnic groups of Iran to in-
ves-tigate CF and CBAVD mutations but there is a little 
infor-mation about the spectrum of CFTR mutations in 
the gen-eral Iranian population and no consensus on the 
mini-mum number of mutations that should be tested 
and un-fortunately at present, the design of a diagnostic 
panel is not possible at the national level. Therefore, it is 
essential that with the advent of fertility assisted repro-
ductive techniques such as ICSI, with the purpose of 
conducting studies, the national panel CF and CBAVD 
have been identified and applied. Totally, the goal of de-
signing a panel of common mutations in each country is 
to help improve the health system and reduce costs. A 
number of topics were identified for future investiga-
tions in the genetic screening of the infertile male. For 
example, what are the long-term health results of chil-
dren born from infertile men, can cost-effective tools for 
genetic screening in men (karyotype, YCMs, and CF-mu-
tation analysis) in low-income settings be developed (4, 
22). There is a necessity for large Iranian population-
based studies to specify the outbreak of genetic causes 
of male infertility in the general population. Systematic 
review and meta-analysis are required to search the ef-
fect of other gene mutations and polymorphisms on in-
fertility.  Ideally, large population-based cohort studies 
managed in a several geographical regions must be per-
formed with constant definitions of male infertility in 
Iranian population and comparable clinical research de-
signs. In addition, the development of techniques such 
as Next Generation Sequencing(NGS) to test for genetic 
anomalies or undesirable polymorphisms before per-
forming ART is important (1,4,139). Finally, the short-
age information in this area reflects the overall scarcity 
of high quality long-term national funding to support re-
productive medicine, and especially male in-fertility. It 




We stated key points for research focus that demand ex-
amination and analysis in Iran. Overall, based on studies 
and findings of this review, the genetic diagnosis of in-
fertility in Iranian men is similar to the rest of the world. 
One high preference area for a survey in idiopathic cases 
is to gain a better perception of the polymorphisms and 
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mutation analysis in the genes responsible for the pro-
cess of spermatogenesis. There is an instant necessity to 
realize these cellular and molecular genetic mecha-
nisms in order to formulate proper diagnostic tests, de-
velop a rational therapy for male infertility. The results 
of this study demonstrated that genetic abnormalities 
happen frequently in Iranian infertile men, which un-
derline the significance of molecular and cytogenetic 
surveys and the relation of its findings in the patient's 
management in the fertility clinics. 
 
6. 6. Recommendations: 
6.1. It may be necessary to re-examine the YCM screen-
ing standards in accordance with the needs of the Ira-
nian infertile men’s community and with the purpose of 
conducting ongoing studies, Iran-specific STR panel has 
been designed. 
6.2. There is a little information about the spectrum of 
CFTR mutations in the general Iranian population and 
no consensus on the minimum number of mutations that 
should be tested and unfortunately at present, the de-
sign of a diagnostic panel is not possible at the national 
level. 
6.3. There is a necessity for large Iranian population-
based studies to specify the prevalence of genetic causes 
of male infertility in the general population. 
Systematic review and meta-analysis are required to in-
vestigate the effect of other gene mutations and poly-
morphisms on infertility. 
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